Unknown

Dataset Information

Ondansetron: recommended antiemetics for patients with acute pancreatitis? a population-based study.


ABSTRACT: Objective: Ondansetron administration is a common antemetic of acute pancreatitis therapy in the intensive care unit (ICU), but its actual association with patients' outcomes has not been confirmed. The study is aimed to determine whether the multiple outcomes of ICU patients with acute pancreatitis could benefit from ondansetron. Methods: 1,030 acute pancreatitis patients diagnosed in 2008-2019 were extracted from the Medical Information Mart for Intensive Care (MIMIC)-IV database as our study cohort. The primary outcome we considered is the 90-day prognosis, and secondary outcomes included in-hospital survival and overall prognosis. Results: In MIMIC-IV, 663 acute pancreatitis patients received ondansetron administration (OND group) during their hospitalization, whil

SUBMITTER: Wu G 

PROVIDER: S-EPMC10205993 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature